| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5657111 | Clinical Gastroenterology and Hepatology | 2017 | 24 Pages |
Abstract
In a case-control study of women with HCC vs female control subjects at a single center, we associated use of estrogen MHT with reduced risk of HCC and increased overall survival times of patients with HCC. Further studies are needed to determine the benefits of estrogen therapy for women and patients with HCC, and effects of tumor expression of estrogen receptor.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Manal M. Hassan, Gehan Botrus, Reham Abdel-Wahab, Robert A. Wolff, Donghui Li, David Tweardy, Alexandria T. Phan, Ernest Hawk, Milind Javle, Ju-Seog Lee, Harrys A. Torres, Asif Rashid, Renato Lenzi, Hesham M. Hassabo, Yasmin Abaza, Ahmed S. Shalaby,